Cargando…

Angiogenesis and Anti-Angiogenic Treatment in Prostate Cancer: Mechanisms of Action and Molecular Targets

Prostate cancer (PC) is the most common cancer in men and the second leading cause of cancer-related death worldwide. Many therapeutic advances over the last two decades have led to an improvement in the survival of patients with metastatic PC, yet the majority of these patients still succumb to the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ioannidou, Evangelia, Moschetta, Michele, Shah, Sidrah, Parker, Jack Steven, Ozturk, Mehmet Akif, Pappas-Gogos, George, Sheriff, Matin, Rassy, Elie, Boussios, Stergios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8472415/ https://www.ncbi.nlm.nih.gov/pubmed/34576107 http://dx.doi.org/10.3390/ijms22189926

Ejemplares similares

Unraveling the Wide Spectrum of Melanoma Biomarkers
por: Revythis, Antonios, et al.
Publicado: (2021)

Development of new poly(ADP-ribose) polymerase (PARP) inhibitors in ovarian cancer: Quo Vadis?
por: Boussios, Stergios, et al.
Publicado: (2020)

Genetic Aberrations of DNA Repair Pathways in Prostate Cancer: Translation to the Clinic
por: Ghose, Aruni, et al.
Publicado: (2021)

Poly (ADP-Ribose) Polymerase Inhibitors: Talazoparib in Ovarian Cancer and Beyond
por: Boussios, Stergios, et al.
Publicado: (2020)

BRCA Mutations in Ovarian and Prostate Cancer: Bench to Bedside
por: Boussios, Stergios, et al.
Publicado: (2022)

Non-Epithelial Ovarian Cancers: How Much Do We Really Know?
por: Cheung, Alison, et al.
Publicado: (2022)

Wise Management of Ovarian Cancer: On the Cutting Edge
por: Boussios, Stergios, et al.
Publicado: (2020)

Epithelial Ovarian Cancer: Providing Evidence of Predisposition Genes
por: Shah, Sidrah, et al.
Publicado: (2022)

Cancer-Associated Thrombosis: A New Light on an Old Story
por: Shah, Sidrah, et al.
Publicado: (2021)

Immuno-oncology: a narrative review of gastrointestinal and hepatic toxicities
por: Boussios, Stergios, et al.
Publicado: (2021)

Neoadjuvant treatment for newly diagnosed advanced ovarian cancer: where do we stand and where are we going?
por: Moschetta, Michele, et al.
Publicado: (2020)

Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study
por: Vassiliou, Anna, et al.
Publicado: (2023)

Combined Strategies with Poly (ADP-Ribose) Polymerase (PARP) Inhibitors for the Treatment of Ovarian Cancer: A Literature Review
por: Boussios, Stergios, et al.
Publicado: (2019)

Aberrations of DNA Repair Pathways in Prostate Cancer—The State of the Art
por: Boussios, Stergios, et al.
Publicado: (2023)

Applications of Proteomics in Ovarian Cancer: Dawn of a New Era
por: Ghose, Aruni, et al.
Publicado: (2022)

Hallmarks of the Tumour Microenvironment of Gliomas and Its Interaction with Emerging Immunotherapy Modalities
por: Linares, Christian A., et al.
Publicado: (2023)

Management of Metastatic Spinal Cord Compression in Secondary Care: A Practice Reflection from Medway Maritime Hospital, Kent, UK
por: Shah, Sidrah, et al.
Publicado: (2021)

The Developing Story of Predictive Biomarkers in Colorectal Cancer
por: Boussios, Stergios, et al.
Publicado: (2019)

HPV and Cervical Cancer: A Review of Epidemiology and Screening Uptake in the UK
por: Choi, Sunyoung, et al.
Publicado: (2023)

Current and future immunotherapy approaches in ovarian cancer
por: Demircan, Nazım Can, et al.
Publicado: (2020)

Narrative review on serous primary peritoneal carcinoma of unknown primary site: four questions to be answered
por: Rassy, Elie, et al.
Publicado: (2020)

Bleomycin-Induced Flagellate Erythema in a Patient Diagnosed with Ovarian Yolk Sac Tumor
por: Boussios, Stergios, et al.
Publicado: (2015)

Systemic anti-cancer treatment in malignant ovarian germ cell tumours (MOGCTs): current management and promising approaches
por: Uccello, Mario, et al.
Publicado: (2020)

Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer
por: Parent, Pauline, et al.
Publicado: (2023)

Surgery for T4 Colorectal Cancer in Older Patients: Determinants of Outcomes
por: Osseis, Michael, et al.
Publicado: (2022)

Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer
por: Revythis, Antonios, et al.
Publicado: (2022)

BRCA Mutations in Prostate Cancer: Assessment, Implications and Treatment Considerations
por: Shah, Sidrah, et al.
Publicado: (2021)

A review on pregnancy complicated by ovarian epithelial and non-epithelial malignant tumors: Diagnostic and therapeutic perspectives
por: Boussios, Stergios, et al.
Publicado: (2018)

Upfront debulking surgery for high-grade serous ovarian carcinoma: current evidence
por: Tsonis, Orestis, et al.
Publicado: (2020)

NOTCH signalling in ovarian cancer angiogenesis
por: Perez-Fidalgo, Jose Alejandro, et al.
Publicado: (2020)

From Biology to Diagnosis and Treatment: The Ariadne’s Thread in Cancer of Unknown Primary
por: Mathew, Beatrice Gadiel, et al.
Publicado: (2023)

The Experience of a Single NHS England Trust on the Impact of the COVID-19 Pandemic on Junior and Middle-Grade Doctors: What Is Next?
por: Revythis, Antonios, et al.
Publicado: (2021)

PARP Inhibitors in Ovarian Cancer: The Route to “Ithaca”
por: Boussios, Stergios, et al.
Publicado: (2019)

Evaluation of the anti-angiogenic action of melatonin in breast cancer
por: Jardim, Bruna V, et al.
Publicado: (2013)

Epilepsy and Diagnostic Dilemmas: The Role of Language and Speech-Related Seizures
por: Papadopoulou, Soultana, et al.
Publicado: (2022)

Dynamics of Neutrophils-to-Lymphocyte Ratio Predict Outcomes of PD-1/PD-L1 Blockade
por: Moschetta, Michele, et al.
Publicado: (2017)

Exosomes in the Diagnosis and Treatment of Renal Cell Cancer
por: Boussios, Stergios, et al.
Publicado: (2023)

Malignant peritoneal mesothelioma: clinical aspects, and therapeutic perspectives
por: Boussios, Stergios, et al.
Publicado: (2018)

Endometriosis-associated ovarian carcinomas: insights into pathogenesis, diagnostics, and therapeutic targets—a narrative review
por: Samartzis, Eleftherios P., et al.
Publicado: (2020)

Biomarkers in Tumor Angiogenesis and Anti-Angiogenic Therapy
por: Pircher, Andreas, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_8muhgvvm7f3imdseobv0ls7dm0